Intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: preliminary results of a prospective randomized cross-over trial

被引:0
|
作者
van Ballegooie, E.
Logtenberg, S. J. J.
Kleefstra, N.
Houweling, S. T.
Groenier, K. H.
Bilo, H. J. G.
机构
[1] Langerhans, Med Res Grp, Zwolle, Netherlands
[2] Bethesda Gen Hosp, Hoogeveen, Netherlands
[3] Isala Clin, Ctr Diabet, Zwolle, Netherlands
[4] UMCG, Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0223
引用
收藏
页码:S97 / S98
页数:2
相关论文
共 50 条
  • [1] Intraperitoneal (IP) insulin infusion versus subcutaneous (SC) insulin administration in type 1 diabetes (T1DM): Preliminary results of a prospective randomized cross-over trial
    Logtenberg, Susan J.
    Kleefstra, Nanne
    Houweling, Sebastiaan T.
    Groenier, Klaas H.
    Van Ballegooie, Evert
    Bilo, Henk J.
    DIABETES, 2007, 56 : A120 - A120
  • [2] Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes A randomized controlled trial
    Logtenberg, Susan J.
    Kleefstra, Nanne
    Houweling, Sebastiaan T.
    Groenier, Klaas H.
    Gans, Reinold O.
    van Ballegooie, Evert
    Bilo, Henk J.
    DIABETES CARE, 2009, 32 (08) : 1372 - 1377
  • [3] CROSS-OVER RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFECT OF TELECARE ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES AND INSULIN-PUMP TREATMENT: PRELIMINARY RESULTS
    Colomo, N.
    Dominguez-Lopez, M.
    Guerrero, M.
    Carreira, M.
    Fontalba, M. I.
    Linares, F.
    Bautista, C.
    Sanchez, I.
    Anarte, M. T.
    Ruiz de Adana, M. S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A102 - A102
  • [4] Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus
    van Dijk, P. R.
    Logtenberg, S. J. J.
    Hendriks, S. H.
    Groenier, K. H.
    Feenstra, J.
    Pouwer, F.
    Gans, R. O. B.
    Kleefstra, N.
    Bilo, H. J. G.
    NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (09):
  • [5] Continuous intraperitoneal insulin infusion versus subcutaneous insulin for type 1 diabetes: a prospective, case-control trial proving non-inferiority
    Bilo, H. J. G.
    van Dijk, P. R.
    Logtenberg, S. J. J.
    Groenier, K. H.
    Feenstra, H.
    Gans, R. O. B.
    Kleefstra, N.
    DIABETOLOGIA, 2014, 57 : S89 - S89
  • [6] A Randomized cross-over trial comparing insulin glargine plus lispro with NPH insulin plus soluble insulin in adolescents with type 1 diabetes
    Murphy, NP
    Keane, SM
    Ong, KK
    Ford-Adams, ME
    Edge, JA
    Dunger, DB
    DIABETES, 2002, 51 : A54 - A54
  • [7] Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes
    Ashwell, SG
    Amiel, SA
    Bilous, RW
    Dashora, U
    Heller, SR
    Hepburn, DA
    Shutler, SD
    Stephens, JW
    Home, PD
    DIABETIC MEDICINE, 2006, 23 (03) : 285 - 292
  • [8] Preliminary results of dapagliflozin in inactive lupus nephritis cross-over randomized trial
    Vajgel, Gisele
    Miranda Filho, Carlos
    Oliveira, Camila
    Costa, Denise Maria
    Silva Junior, Braziliano
    Lima, Camilla
    Sandrin-Garcia, Paula
    Valente, Lucila
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [9] EFFECTS OF INTRAPERITONEAL VERSUS SUBCUTANEOUS INSULIN ADMINISTRATION ON LIPOPROTEIN METABOLISM IN TYPE-I DIABETES
    RUOTOLO, G
    MICOSSI, P
    GALIMBERTI, G
    LIBRENTI, MC
    PETRELLA, G
    MARCOVINA, S
    POZZA, G
    HOWARD, BV
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (06): : 598 - 604
  • [10] Preliminary results of dapagliflozin in inactive lupus nephritis cross-over randomized trial
    Vajgel, Gisele
    Miranda Filho, Carlos
    Oliveira, Camila
    Costa, Denise Maria
    Silva Junior, Braziliano
    Lima, Camilla
    Sandrin-Garcia, Paula
    Valente, Lucila
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I514 - I514